Sort   by:  
 Page size 
UnknownDrug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs
Not available
S-EPMC12299139 | biostudies-literature
UnknownEmerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Not available
S-EPMC7696369 | biostudies-literature
UnknownNovel immunotherapy strategies for treatment of neuroendocrine neoplasms.
Not available
S-EPMC7530319 | biostudies-literature
UnknownNETs: organ-related epigenetic derangements and potential clinical applications.
Not available
S-EPMC5302998 | biostudies-literature
UnknownAnalysis of the immune landscape of small bowel neuroendocrine tumors.
Not available
S-EPMC7787268 | biostudies-literature
UnknownMechanisms of Anticancer Drug Resistance in Hepatoblastoma.
Not available
S-EPMC6468761 | biostudies-literature
UnknownA Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms.
Not available
S-EPMC7771542 | biostudies-literature
UnknownOsteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.
Not available
S-EPMC5410243 | biostudies-literature
UnknownAngiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications.
Not available
S-EPMC9428554 | biostudies-literature
UnknownGa-68-Edotreotide PET/CT SSTR Total Tumor Volume as a Predictor of Outcome in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors.
Not available
S-EPMC12833188 | biostudies-literature
Sort   by:  
 Page size